Literature DB >> 9875331

Membrane permeability induced by hepatitis A virus proteins 2B and 2BC and proteolytic processing of HAV 2BC.

M Jecht1, C Probst, V Gauss-Müller.   

Abstract

The ability to rearrange membranes is a unique feature of nonstructural proteins 2B, 2C, and 2BC of some picornaviruses. To analyze in detail membrane binding of the respective proteins of hepatitis A virus (HAV), they were transiently expressed in the vaccinia/T7 system, and their effect on membrane permeability was studied using beta-galactosidase as reporter. Although 2C had no effect, the significantly increased reporter activity observed in the extracellular space of 2B- and 2BC-expressing cells points to a specific effect of HAV proteins 2B and 2BC on membrane permeability. In biochemical fractionation studies, HAV 2C and 2BC showed properties of intregral membrane proteins, whereas 2B was associated with membranes as a peripheral protein. Proteinase 3C-mediated cleavage of precursor 2BC in vivo was most efficient when the enzyme was coexpressed in its precursor forms P3 or 3ABC, which both include the membrane-anchoring domain 3A. 3ABC showed the same solubility pattern as 2BC, suggesting that colocalization of 2BC and 3ABC might be required for the efficient liberation of 2B and 2C and occurs on membranes that have been proposed as the site of viral RNA replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875331     DOI: 10.1006/viro.1998.9451

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

Authors:  A Deora; L Ratner
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC.

Authors:  Y Kusov; V Gauss-Müller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Structural basis for host membrane remodeling induced by protein 2B of hepatitis A virus.

Authors:  Laia Vives-Adrián; Damià Garriga; Mònica Buxaderas; Joana Fraga; Pedro José Barbosa Pereira; Sandra Macedo-Ribeiro; Núria Verdaguer
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.

Authors:  Huisheng Liu; Zixiang Zhu; Qiao Xue; Fan Yang; Weijun Cao; Keshan Zhang; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 6.  Hepatitis A Virus Genome Organization and Replication Strategy.

Authors:  Kevin L McKnight; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

7.  Cloning, purification and preliminary crystallographic studies of the 2AB protein from hepatitis A virus.

Authors:  Damià Garriga; Laia Vives-Adrián; Mònica Buxaderas; Frederico Ferreira-da-Silva; Bruno Almeida; Sandra Macedo-Ribeiro; Pedro José Barbosa Pereira; Núria Verdaguer
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-29

8.  Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus.

Authors:  Y S Chang; C L Liao; C H Tsao; M C Chen; C I Liu; L K Chen; Y L Lin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Processing map and essential cleavage sites of the nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome.

Authors:  Stanislav V Sosnovtsev; Mark Garfield; Kim Y Green
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities.

Authors:  Keiichi Fujiwara; Osamu Yokosuka; Fumio Imazeki; Makoto Miki; Kazuyuki Suzuki; Kiwamu Okita; Eiji Tanaka; Masao Omata
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.